galleon pharmaceuticals

Galleon is focusing our efforts on well-defined markets associated with high morbidity and mortality. Our initial product development efforts are aimed towards treating / preventing respiratory depression in a post-surgical setting. Our oral products are focused on a subset of sleep apnea patients and at risk (for respiratory depression) chronic pain patients.

Management